Monopar Therapeutics
MNPR
#7537
Rank
C$0.67 B
Marketcap
C$98.95
Share price
-1.84%
Change (1 day)
-23.36%
Change (1 year)

EPS for Monopar Therapeutics (MNPR)

EPS in 2026 (TTM): C-$2.66

According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is C-$2.74. In 2025 the company made an earnings per share (EPS) of C-$2.65 an increase over its 2024 EPS that were of C-$5.89.

EPS history for Monopar Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$2.660.44%
2025C-$2.65-54.99%
2024C-$5.8935.2%
2023C-$4.36-26.75%
2022C-$5.9513.7%
2021C-$5.2325.86%
2020C-$4.1628.89%
2019C-$3.2345.28%
2018C-$2.22-80.5%
2017C-$11.391296.33%
2016C-$0.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
C-$1.94-29.32%๐Ÿ‡บ๐Ÿ‡ธ USA